반응식
[Br:1][C:2]1[CH:3]=[CH:4][C:5]([C:14]([OH:16])=O)=[N:6][C:7]=1[O:8][CH2:9][C:10]([F:13])([F:12])[F:11].Cl.[S:18]1[CH:22]=[CH:21][N:20]=[C:19]1[C:23]1([NH2:27])[CH2:26][O:25][CH2:24]1>>[S:18]1[CH:22]=[CH:21][N:20]=[C:19]1[C:23]1([NH:27][C:14]([C:5]2[CH:4]=[CH:3][C:2]([Br:1])=[C:7]([O:8][CH2:9][C:10]([F:11])([F:12])[F:13])[N:6]=2)=[O:16])[CH2:26][O:25][CH2:24]1참가 물질
3
실험 절차
The title compound was synthesized in analogy to Example 280c, using 5-bromo-6-(2,2,2-trifluoro-ethoxy)-pyridine-2-carboxylic acid (Example 282a) and 3-(thiazol-2-yl)oxetan-3-amine hydrochloride (Example 281b) as starting materials, MS (EI): m/e=438.0 [M+H]+.
출처 및 근거
- ORD 기록
- ord-8c190e0d7a5e462fb9ab2471ef3a870d
- 출처 데이터셋
- uspto-grants-2016_04
- 특허 번호
- US09321727B2
연결된 노트
불러오는 중…